At first glance, 2014 may seem like a year dominated by disease outbreaks, from polio's reemergence in parts of Asia to the Ebola epidemic that still continues to make headlines. But a closer look indicates 2014 was replete with regulatory rulings, big investments in genomic medicine and activism in the name of research funding.
- Manasi Vaidya
- Shraddha Chakradhar